Delhi High Court also issued notice to the Centre on two pleas to make the second dose of both vaccines against COVID-19 Covaxin and Covishield available in the national capital
The Problems With One-Dose Covishield
If Covishield is administered as a single-dose vaccine, a small study found its efficacy against symptomatic COVID-19 caused by the B.1.617.2 variant is only 33%.
Photo: Artem Podrez/Pexels
Health4 hours ago
On May 31, NDTV quoted unnamed sources in the Indian government saying it will be conducting a study to assess the feasibility of deploying the Covishield vaccine in a single-dose regimen instead of continuing the extant double-dose regimen.
At any other time, such a statement may have been sufficient to believe the government would organise and conduct a well-designed trial, publicise the findings and revise policy (or not) to stay in line with the findings, informed by socio-economic considerations. But the last 15 months have thrown up enough incidents of public-health malpractice on the state’s part to make such hope foolish. There is a nontrivial chance, especially if the vaccine shortage persists and the outbreaks on an upward tr
The Latest: Moderna seeks full FDA approval for its vaccine
The Associated Press
FacebookTwitterEmail 23
1of23FILE - In this March 7, 2021 file photo an advertising figure for Covid-19 rapid test stands in front of a small test center in Frankfurt, Germany.Michael Probst/APShow MoreShow Less
2of23Doctor Carolina Moreira, left, checks on Elizabeth Cervino, 87, during her rounds visiting COVID-19 patients at their homes amid the new coronavirus pandemic in Montevideo, Uruguay, Monday, May 31, 2021.Matilde Campodonico/APShow MoreShow Less
3of23
4of23Students wearing face masks to help prevent the spread of the coronavirus attend class at a school, in Peshawar, Pakistan, Tuesday, June 1, 2021. Pakistani authorities reopened schools of grade 10 and 12 following a steady decrease in deaths and infections from the coronavirus.Muhammad Sajjad/APShow MoreShow Less